(RTTNews) - Monday, Vanda Pharmaceuticals Inc. (VNDA:
News ) said its third-quarter net loss narrowed to $7.72 million from $10.86 million in the prior year period.
Net loss per share attributable to common stockholders for the quarter also narrowed to $0.28 from $0.41 in the year-ago period. On average, 2 analysts polled by Thomson Reuters expected the company to report a loss of $0.31 per share for the quarter.
Click here to receive FREE breaking news email alerts for VANDA PHARMACEUTICALS and others in your portfolio
by RTT Staff Writer
For comments and feedback: contact editorial@rttnews.com